Walleye Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Walleye Capital's ABBV Position: Q3 2026 in Review
Walleye Capital increased its AbbVie (ABBV) stake by 4,561% in Q3 2026, buying an estimated $15.4M and bringing the position to 61,566 shares worth $16.1M. The position accounts for 0.01% of the portfolio, ranked #911.
Walleye Capital first reported a position in ABBV in Q1 2019 and has held it in 22 quarters since. The position peaked at $43.1M in Q3 2025. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Walleye Capital held 61,566 shares of AbbVie worth $16.1M as of Q3 2026.
- Walleye Capital bought 60,245 AbbVie shares in Q3 2026, an estimated $15.4M.
- AbbVie made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #911 holding.
- Walleye Capital first reported a position in AbbVie in Q1 2019 and has held it in 22 quarters since.
- Walleye Capital's AbbVie position peaked at $43.1M in Q3 2025.
- 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.